Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

Abstract Background The PRediction of short-term Outcome in preGNant wOmen with Suspected preeclampsIa Study (PROGNOSIS) demonstrated that a soluble fms-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF) ratio ≤ 38 ruled out the occurrence of preeclampsia in the next week with a negative p...

Full description

Bibliographic Details
Main Authors: Dietmar Schlembach, Martin Hund, Annabel Schroer, Cyrill Wolf
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Health Services Research
Subjects:
Angiogenic factors
Cost-effectiveness
Cost-saving
Diagnosis
Economic
Diagnosis-related group
Online Access:http://link.springer.com/article/10.1186/s12913-018-3406-1

Internet

http://link.springer.com/article/10.1186/s12913-018-3406-1

Similar Items